USPTO serial 79285587
PANBIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 8, 2021
- Examiner
- GUROK, GALINA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PANBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Abbott Rapid Diagnostics International Subsidiary Unlimited Company
IE
Other trademarks owned by Abbott Rapid Diagnostics International Subsidiary Unlimited Company
Abbott Rapid Diagnostics International Subsidiary Unlimited Company
IE
Other trademarks owned by Abbott Rapid Diagnostics International Subsidiary Unlimited Company
Abbott Rapid Diagnostics International Subsidiary Unlimited Company
IE
Other trademarks owned by Abbott Rapid Diagnostics International Subsidiary Unlimited Company
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michele H. Bowman
Michele H. Bowman Abbott Laboratories100 Abbott Park RoadAbbott LaboratoriesAbbott Park, IL 60064Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Control preparations for in vitro diagnostic testing, screening, confirmation and analysis, namely, diagnostic preparations for scientific or research use; diagnostic reagents and chemical reagents for laboratory or research purposes; chemical reagents, namely, solutions used in diagnostic test kits for laboratory or research purposes; chemically-treated nonmedical test strips for laboratory or research purposes for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; diagnostic test kits comprised of reagents for use in diagnostic tests for laboratory or research use; diagnostic preparations for laboratory or research use; diagnostic test kits comprising reagents and assays for laboratory or research use; in vitro diagnostic tests, namely, chemical reagents and assays for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections for laboratory or research use, other than for medical or veterinary use; in vitro immunochromatographic tests, namely, chemical reagents and assays for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections for laboratory or research use, other than for medical or veterinary use | ACTIVE | — |
| 005 | Diagnostic kits comprising medical diagnostic bioreagents for testing blood, bodily fluid, nasal samples, oral samples and tissue for use in the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; medical diagnostic test strips for testing blood, human serum, plasma, bodily fluid, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue for use in the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic reagents; diagnostic preparations for medical purposes; testing preparations for medical use, namely, diagnostic preparations; diagnostic tests for medical use, namely, medical diagnostic test media in the form of strips, cassettes, cartridges, and cards for the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue; in vitro medical diagnostic tests, namely, medical diagnostic test media in the form of strips, cassettes, cartridges, and cards for the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; in vitro medical diagnostic assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue; in vitro medical diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; in vitro medical diagnostic test strips for use in the field of infectious disease; in vitro medical diagnostic reagents; in vitro immunochromatographic tests for medical use, namely, medical diagnostic reagents and assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue; medical diagnostics tests for the detection, diagnosis, screening, and confirmation of infections, namely, medical diagnostic reagents and assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Abbott Rapid Diagnostics International Subsidiary Unlimited Company
- Other trademarks owned by Abbott Rapid Diagnostics International Subsidiary Unlimited Company
- Other trademarks owned by Abbott Rapid Diagnostics International Subsidiary Unlimited Company
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named PANBIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 8, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 3, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 5, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 15, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 28, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Sep 28, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Sep 8, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 8, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 23, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 23, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 21, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 3, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 3, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 3, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 16, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 9, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 8, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 8, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 25, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 6, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 6, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 1, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 30, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 25, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 19, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 15, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 14, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |